Terug
Dagbereik
€ 8,05
€ 8,52
52-Weeksbereik
€ 5,41
€ 12,49
Volume
1.405.898
50D / 200D Gem.
€ 8,55
/
€ 8,54
Vorige Slotkoers
€ 8,26
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,6 | 0,4 |
| P/B | 4,2 | 2,9 |
| ROE % | -94,8 | 3,7 |
| Net Margin % | -413,0 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 28,20
+238.9%
Low: € 15,00
High: € 40,00
Forward WPA
-€ 3,52
Omzet Sch.
120 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,93
€ 0,75 – € 11,59
|
1,3 B | 3 |
| FY2029 |
€ 0,74
€ 0,14 – € 2,18
|
740 M | 3 |
| FY2028 |
-€ 1,44
-€ 3,62 – € 3,48
|
410 M | 9 |
Belangrijkste Punten
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -70,70M
Capital efficient — spends only 9,84% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)25,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-94,82%
ROIC-117,03%
Net Margin-412,95%
Op. Margin-449,94%
Veiligheid
Debt / Equity
0,12
Current Ratio6,06
Interest Coverage-200,81
Waardering
P/E Ratio
-2,64
P/B Ratio4,22
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25,24% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67,48M | Net Income (TTM) | -278,67M |
| ROE | -94,82% | ROA | -37,74% |
| Gross Margin | 99,92% | Operating Margin | -449,94% |
| Net Margin | -412,95% | Free Cash Flow (TTM) | -70,70M |
| ROIC | -117,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 6,06 |
| Interest Coverage | -200,81 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -2,64 | P/B Ratio | 4,22 |
| P/S Ratio | 10,89 | PEG Ratio | -0,06 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 734,90M | Enterprise Value | 606,26M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 67,48M | 53,88M | 0,0 | 0,0 | 0,0 |
| Net Income | -278,67M | -173,98M | -152,63M | -135,84M | -130,47M |
| EPS (Diluted) | -3,18 | -2,02 | -2,08 | -2,03 | -1,97 |
| Gross Profit | 67,43M | 53,88M | -849.000,0 | 0,0 | 0,0 |
| Operating Income | -303,63M | -193,20M | -165,80M | -139,87M | -131,26M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 738,36M | 760,16M | 448,94M | 456,31M | 534,05M |
| Total Liabilities | 564,23M | 346,52M | 51,66M | 36,03M | 27,44M |
| Shareholders' Equity | 174,14M | 413,64M | 397,27M | 420,28M | 506,61M |
| Total Debt | 20,46M | 16,59M | 17,20M | 14,02M | 6,88M |
| Cash & Equivalents | 149,10M | 224,46M | 37,32M | 51,80M | 90,67M |
| Current Assets | 708,66M | 744,83M | 432,48M | 446,43M | 522,29M |
| Current Liabilities | 116,97M | 78,71M | 35,26M | 24,06M | 22,46M |